Novartis Ireland Limited

Lobbying Organisation Novartis Ireland Limited

Date published 20 Sep, 2016

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 May, 2016 to 31 Aug, 2016

Specific Details Make heart failure (HF) a health policy priority - update on initiatives taking place in the West

Intended results Support for heart failure as health policy priority at an Irish and European level

Name of person primarily responsible for lobbying on this activity Susanne O'Reilly (Government and External Affairs)

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (1)

90,000 people have heart failure (HF) in Ireland. Need to have a similar initiative in HF, like stroke. There is also profound regional disparity in the management of HF in Ireland. Update on HF initiatives in the West of Ireland: HF Patient Academy – Croi Galway HF health outcomes project HF Awareness at the Ploughing Championships EU HF Policy Network

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Mairead McGuinness MEP (European Parliament)